In the study reported here, albeit in a limited sample size, early transcriptional levels of AKAP7 exhibited an ability to predict post-stroke BBB disruption with levels of diagnostic performance exceeding those reported with regards to a majority of previously proposed biomarkers; these findings make AKAP7 a candidate for further clinical evaluation with regards to biomarker use. Here, AKAP7 is linked to stroke disorder.